Private-label Potential ARKRAY USA already serves as a private-label blood glucose meter manufacturer for a major retailer, indicating strong OEM/white-label capabilities and potential for expanding private-label partnerships with additional retailers, clinics, and pharmacy chains.

Healthcare Partnerships Past and ongoing collaborations with clinical management platforms and care networks (e.g., Rimidi) suggest opportunities to bundle ARKRAY diabetes care products with digital health tools, remote monitoring solutions, and care coordination services.

Expanded Product Access A history of launching disposable and safety products (assure safety pen needles, safety features) implies doors open for selling complementary safe-use devices and patient/clinician accessories to hospitals, long-term care facilities, and ambulatory centers.

Clinical Reach Longstanding focus on both diabetes care and clinical chemistry equipment positions ARKRAY to target mixed portfolios in clinics, labs, and private clinics that require integrated testing solutions and compatible point-of-care devices.

Innovation Heritage Being an innovator with milestones like early HbA1c analyzers signals credibility for prospecting health systems and distributors seeking proven technology leadership, enabling value-based pitches around reliability, training, and ongoing support.